Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
View stock
VS
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24.5 billion of revenue in 2025 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
View stock

Stock highlights

Stock comparison highlights
Stock name
Cellyan BiotechnologyUnion Pacific
Last price
$1.48$304.11
Currency
USD
USD
$1.9M$180B
-23.56
-$1.39$12.82
-0.95
0$5.56
01.88%
Sector
MobilityMobility
Employees
1128,658
Ticker
$HKPD$UNP
Primary listing
NASDAQNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $HKPD or $UNP on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.